Aurora Spine Corp (ASG) - Net Assets
Based on the latest financial reports, Aurora Spine Corp (ASG) has net assets worth CA$3.62 Million CAD (≈ $2.62 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$9.71 Million ≈ $7.03 Million USD) and total liabilities (CA$6.09 Million ≈ $4.40 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Aurora Spine Corp (ASG) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$3.62 Million |
| % of Total Assets | 37.3% |
| Annual Growth Rate | 27.72% |
| 5-Year Change | -31.54% |
| 10-Year Change | 9.87% |
| Growth Volatility | 217.01 |
Aurora Spine Corp - Net Assets Trend (2012–2025)
This chart illustrates how Aurora Spine Corp's net assets have evolved over time, based on quarterly financial data. See Aurora Spine Corp defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Aurora Spine Corp (2012–2025)
The table below shows the annual net assets of Aurora Spine Corp from 2012 to 2025. For live valuation and market cap data, see ASG market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CA$3.81 Million ≈ $2.76 Million |
-13.29% |
| 2024-12-31 | CA$4.40 Million ≈ $3.18 Million |
-16.99% |
| 2023-12-31 | CA$5.30 Million ≈ $3.83 Million |
+22.71% |
| 2022-12-31 | CA$4.32 Million ≈ $3.12 Million |
-22.49% |
| 2021-12-31 | CA$5.57 Million ≈ $4.03 Million |
+69.73% |
| 2020-12-31 | CA$3.28 Million ≈ $2.37 Million |
+85.59% |
| 2019-12-31 | CA$1.77 Million ≈ $1.28 Million |
-40.23% |
| 2018-12-31 | CA$2.96 Million ≈ $2.14 Million |
+79.13% |
| 2017-12-31 | CA$1.65 Million ≈ $1.19 Million |
-52.41% |
| 2016-12-31 | CA$3.47 Million ≈ $2.51 Million |
-26.06% |
| 2015-12-31 | CA$4.69 Million ≈ $3.39 Million |
+34.12% |
| 2014-12-31 | CA$3.50 Million ≈ $2.53 Million |
+142.93% |
| 2013-12-31 | CA$1.44 Million ≈ $1.04 Million |
+808.68% |
| 2012-12-31 | CA$158.51K ≈ $114.66K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Aurora Spine Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2606364100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$31.32 Million | 821.51% |
| Total Equity | CA$3.81 Million | 100.00% |
Aurora Spine Corp Competitors by Market Cap
The table below lists competitors of Aurora Spine Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mico BioMed Co. Ltd.
KQ:214610
|
$13.00 Million |
|
Moleculin Biotech Inc
NASDAQ:MBRX
|
$13.02 Million |
|
Prochem S.A.
WAR:PRM
|
$13.02 Million |
|
SSR Inc
KQ:275630
|
$13.03 Million |
|
Wooree Lighting Co.Ltd
KQ:037400
|
$12.98 Million |
|
OSR Holdings Inc
NASDAQ:OSRH
|
$12.98 Million |
|
Bd Multimedia
PA:ALBDM
|
$12.97 Million |
|
High Coast Distillery AB
ST:HIGHCO-B
|
$12.97 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aurora Spine Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,397,261 to 3,812,714, a change of -584,547 (-13.3%).
- Net loss of 731,120 reduced equity.
- Other factors increased equity by 146,573.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-731.12K | -19.18% |
| Other Changes | CA$146.57K | +3.84% |
| Total Change | CA$- | -13.29% |
Book Value vs Market Value Analysis
This analysis compares Aurora Spine Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.71x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 9.55x to 4.71x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | CA$0.02 | CA$0.23 | x |
| 2014-12-31 | CA$0.16 | CA$0.23 | x |
| 2015-12-31 | CA$0.18 | CA$0.23 | x |
| 2016-12-31 | CA$0.11 | CA$0.23 | x |
| 2017-12-31 | CA$0.05 | CA$0.23 | x |
| 2018-12-31 | CA$0.07 | CA$0.23 | x |
| 2019-12-31 | CA$0.04 | CA$0.23 | x |
| 2020-12-31 | CA$0.06 | CA$0.23 | x |
| 2021-12-31 | CA$0.09 | CA$0.23 | x |
| 2022-12-31 | CA$0.06 | CA$0.23 | x |
| 2023-12-31 | CA$0.07 | CA$0.23 | x |
| 2024-12-31 | CA$0.06 | CA$0.23 | x |
| 2025-12-31 | CA$0.05 | CA$0.23 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aurora Spine Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -19.18%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.98%
- • Asset Turnover: 1.76x
- • Equity Multiplier: 2.73x
- Recent ROE (-19.18%) is above the historical average (-131.51%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -911.84% | 0.00% | 0.00x | 2.45x | CA$-1.46 Million |
| 2013 | -237.38% | -1651.78% | 0.08x | 1.74x | CA$-3.56 Million |
| 2014 | -214.55% | -289.79% | 0.32x | 2.33x | CA$-7.86 Million |
| 2015 | -62.14% | -59.51% | 0.61x | 1.70x | CA$-3.39 Million |
| 2016 | -48.39% | -24.85% | 0.96x | 2.03x | CA$-2.03 Million |
| 2017 | -135.67% | -37.41% | 1.13x | 3.20x | CA$-2.41 Million |
| 2018 | -2.31% | -0.79% | 1.27x | 2.31x | CA$-364.02K |
| 2019 | -70.94% | -11.25% | 1.67x | 3.77x | CA$-1.43 Million |
| 2020 | -7.07% | -2.68% | 1.21x | 2.18x | CA$-560.22K |
| 2021 | -42.36% | -22.37% | 1.00x | 1.90x | CA$-2.92 Million |
| 2022 | -34.78% | -10.09% | 1.47x | 2.34x | CA$-1.93 Million |
| 2023 | -31.72% | -11.57% | 1.21x | 2.26x | CA$-2.21 Million |
| 2024 | -22.80% | -5.71% | 1.59x | 2.51x | CA$-1.44 Million |
| 2025 | -19.18% | -3.98% | 1.76x | 2.73x | CA$-1.11 Million |
Industry Comparison
This section compares Aurora Spine Corp's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $7,154,816
- Average return on equity (ROE) among peers: -15.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aurora Spine Corp (ASG) | CA$3.62 Million | -911.84% | 1.68x | $12.99 Million |
| MedX Health Corp (MDX) | $-2.39 Million | 0.00% | 0.00x | $11.86 Million |
| NuGen Medical Devices Inc (NGMD) | $-2.26 Million | 0.00% | 0.00x | $3.28 Million |
| Perimeter Medical Imaging AI Inc (PINK) | $26.11 Million | -13.74% | 0.33x | $27.98 Million |
| Profound Medical Corp (PRN) | $31.18 Million | -91.63% | 0.41x | $253.09 Million |
| Therma Bright Inc (THRM) | $-3.54 Million | 0.00% | 0.00x | $2.10 Million |
| Theralase Technologies Inc. (TLT) | $3.39 Million | 0.38% | 0.05x | $49.19 Million |
| VentriPoint Diagnostics Ltd (VPT) | $-2.40 Million | 0.00% | 0.00x | $16.97 Million |
About Aurora Spine Corp
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar inter… Read more